                               SEQUENCE LISTING	

<110> FOUNDATION MEDICINE, INC.

<120> MULTIGENE ANALYSIS OF TUMOR SAMPLES

<130> F2036-7056WO

<140> 
<141> 

<150> 62/088,457
<151> 2014-12-05

<160> 3    

<170> PatentIn version 3.5

<210> 1
<211> 150
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide 

<220>
<221> modified_base
<222> (16)..(135)
<223> a, c, t, g, unknown or other

<400> 1
atcgcaccag cgtgtnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn       60

nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn      120

nnnnnnnnnn nnnnncactg cggctcctca                                       150


<210> 2
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
aatgatacgg cgaccaccga gat                                               23


<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 3
caagcagaag acggcatacg a                                                 21